What Makes Your IMMUNITY Heroes Fight Cancer?

What Makes Your IMMUNITY Heroes Fight Cancer?

Author: Dr. Dino Prato - Envita Medical Centers January 16, 2026 Duration: 10:17
Your body is a city — and your immune system is its army. Every day, it stops thousands of threats without you ever knowing. But when cancer learns to hide behind fake ID badges, jam the “radio signals,” or build stromal barriers, the immune system can lose its ability to see the enemy. In this powerful episode of Outsmart Cancer, Dr. Dino Prato, founder of Envita Medical Centers, uses storytelling to explain exactly how the immune system works — and how cancer escapes detection. From neutro...

For anyone navigating a cancer diagnosis, the standard treatment path can feel both overwhelming and impersonal. OutSmart Cancer-Precision Oncology. Less Guess Work. More Life! moves beyond that generic approach, diving into the nuanced world of personalized medicine. Hosted by Dr. Dino Prato, founder of Envita Medical Centers, conversations here are built on a quarter-century of clinical experience helping patients for whom conventional protocols weren't enough. You'll hear detailed discussions that demystify complex topics like genomic testing, targeted therapies, and how integrative strategies can support the body during treatment. This isn't about promoting easy answers; it's about exploring the detailed, often overlooked factors that influence cancer progression and recovery. Each episode aims to translate cutting-edge science and hard-earned clinical wisdom into actionable knowledge, empowering you and your loved ones to ask better questions and understand the full spectrum of options. Tune in for a resource that treats your journey with the specificity it deserves, fostering informed dialogue between patients and their healthcare teams. This podcast serves as a guide for those determined to look deeper into their care, emphasizing a strategy tailored to the individual rather than the disease alone.
Author: Language: en-us Episodes: 100

OutSmart Cancer - Precision Oncology. Less Guess Work. More Life!
Podcast Episodes
Your Doctor Will Miss Aggressive Cancer, Here Is Why [not-audio_url] [/not-audio_url]

Duration: 11:18
Some cancers can progress rapidly, even in weeks, often outpacing conventional drug treatments. This video highlights the critical need for proper testing and targeted cancer therapy to address these aggressive forms of…
The Real Reason Cancer Comes Back Even After Remission [not-audio_url] [/not-audio_url]

Duration: 9:06
Cancer recurrence often stems from dormant cancer cells, not just the primary tumor. These "sleeper cells" can reawaken years later, leading to metastasis. This video presents a smarter approach to cancer treatment, focu…
Blood Cancer Recurrence Isn't Treatment Failure—It's This [not-audio_url] [/not-audio_url]

Duration: 11:36
This video explains why blood cancer can recur, often due to minimal residual disease (MRD) that goes undetected despite initial treatment success. We discuss how initial improvements in scans and blood counts can be mis…
When Standard Immunotherapy Doesn't Work, Try This Instead [not-audio_url] [/not-audio_url]

Duration: 18:55
In this episode, Dr. Dino Prato navigates the complexities of treating cancers that appear invisible to the immune system, making traditional immunotherapy for cancer less effective. He explains how building custom immun…
Cancer Patients Are Told to Eat Anything | That's Killing Them [not-audio_url] [/not-audio_url]

Duration: 12:38
This video clarifies why the common advice to "eat whatever you want" during cancer treatment is misleading, emphasizing that food provides crucial signaling for your body. We explore how nutrition impacts your immune sy…
Anktiva | Cancer Immune Stimulation Isn't Enough Without This? [not-audio_url] [/not-audio_url]

Duration: 21:19
Anktiva is an exciting new cancer immunotherapy that helps the immune system fight and kill cancer cells. Doctors believe it could support treatment for many cancers when used in the right personalized combinations — but…